Phase 3 clinical trial has been given approval by FDA
The FDA has given Ocugen permission to start their phase 3 gene therapy clinical trial for retinitis pigmentosa (RP).
Search
Search results
Belite Bio announces promising phase 3 results for Stargardt disease
The latest research news from Retina UK.
Webinar: Career pathways for young people with sight loss
The latest webinar from Retina UK.
Children and young people
Different inherited sight loss conditions present noticeable symptoms at different times.
Research news round-up – Spring 2024
A round-up of the latest research into inherited retinal conditions - February 2024.
Information for teachers
If you have a child with a visual impairment joining your class, you may have questions about how best you can teach and help them.
Disability sector calling for cost of living support
Retina UK has joined with more than 80 disability charities who have today written to the Chancellor calling for urgent support with the cost of living for disabled people.
Chester Marathon 2026
Join #TeamRetinaUK at the Chester Marathon 2026 and proudly run in support of our vital work.
Giving in memory
Celebrate the life of your loved one, by donating in their memory and help us fund more research and support, now.
Wedding Fundraising
Find out how you can mark your special day while fundraising for people with inherited sight loss.